AbbVies PEARL-III study meets main.

AbbVie’s PEARL-III study meets main, secondary endpoints in individuals with chronic GT1b HCV infection The first detailed results from AbbVie's pivotal stage III research, PEARL-III, were presented today within the… Read more »

Because the prehistoric times.

5 will need to have antifungal herbs for every pantry Fungal infections are one of the most common diseases known to humanity. Because the prehistoric times, humans have got struggled… Read more »

Hans-Christoph Diener.

Power and sample size were determined with the use of the dual success criteria, incorporating a group sequential-analysis plan with five interim analyses for efficacy, futility, and safety. After the… Read more »

Alion awarded $1.

Alion awarded $1.4M Army contract to build up affordable robotic prosthetic device Since 2003, 1,145 soldiers serving in Afghanistan and Iraq experienced a limb amputated. In response, Alion Technology and… Read more »

Wip1 phosphatase.

A*STAR scientists discover potential target to weed out progression of cancer This discovery could eradicate cancers more effectively and prevent relapses Scientists at A*STAR have discovered an enzyme, Wip1 phosphatase,… Read more »

Page 5 of 41« First...2345678...203040...Last »